Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Harald Mangge

Showing results (1-10 of 164) with videos related to

Pageof 17
Sort By:
Nestle Nutrition Institute Workshop Series|January 15, 2016
Beyond Cholesterol - New Cardiovascular BiomarkersHarald Mangge
Nutrients|June 13, 2025
Lipid Metabolism and Relevance to Chronic DiseaseHarald Mangge
Clinical Chemistry and Laboratory Medicine|July 10, 2016
Reply to: Comparing the visco-elastomeric fibrin polymerization assays FIBTEM® (ROTEM) vs. Functional Fibrinogen® (TEG): or why is a higher threshold for fibrinogen substitution better than a lower one? By Schöchl et alFlorian Prüller, Harald Mangge
Molecules (Basel, Switzerland)|August 28, 2019
Immune-Mediated Inflammation in Vulnerable Atherosclerotic PlaquesHarald Mangge, Gunter Almer
Clinical Laboratory|January 25, 2021
Comparison of Automated Procalcitonin Immunoassays under Routine ConditionsTobias Niedrist, Harald Mangge, Markus Herrman
Stroke|May 27, 2006
Hypoadiponectinemia as a risk factor for atherosclerosis?Stefan Pilz, Karine Sargsyan, Harald Mangge
Immunobiology|November 20, 2002
Do chemokines spark autoimmunity in juvenile and adult rheumatic disease?Harald Mangge, Jelena Vojinovic, Konrad Schauenstein
The Journal of Rheumatology|December 17, 2003
Atopic dermatitis as a side effect of anti-tumor necrosis factor-alpha therapyHarald Mangge, Sonja Gindl, Harald Kenzian, et al.
Current Medicinal Chemistry|July 17, 2015
Lipoprotein-Related and Apolipoprotein-Mediated Delivery Systems for Drug Targeting and ImagingGunter Almer, Harald Mangge, Andreas Zimmer, et al.
European Heart Journal|June 23, 2023
SGLT2 inhibition could potentially impact inflammation in acute myocardial infarctionHarald Sourij, Faisal Aziz, Harald Mangge, et al.
Pageof 17

Showing results (1-10 of 164) with videos related to

Sort By:
Pageof 17
Nestle Nutrition Institute Workshop Series|January 15, 2016
Beyond Cholesterol - New Cardiovascular BiomarkersHarald Mangge
Nutrients|June 13, 2025
Lipid Metabolism and Relevance to Chronic DiseaseHarald Mangge
Clinical Chemistry and Laboratory Medicine|July 10, 2016
Reply to: Comparing the visco-elastomeric fibrin polymerization assays FIBTEM® (ROTEM) vs. Functional Fibrinogen® (TEG): or why is a higher threshold for fibrinogen substitution better than a lower one? By Schöchl et alFlorian Prüller, Harald Mangge
Molecules (Basel, Switzerland)|August 28, 2019
Immune-Mediated Inflammation in Vulnerable Atherosclerotic PlaquesHarald Mangge, Gunter Almer
Clinical Laboratory|January 25, 2021
Comparison of Automated Procalcitonin Immunoassays under Routine ConditionsTobias Niedrist, Harald Mangge, Markus Herrman
Stroke|May 27, 2006
Hypoadiponectinemia as a risk factor for atherosclerosis?Stefan Pilz, Karine Sargsyan, Harald Mangge
Immunobiology|November 20, 2002
Do chemokines spark autoimmunity in juvenile and adult rheumatic disease?Harald Mangge, Jelena Vojinovic, Konrad Schauenstein
The Journal of Rheumatology|December 17, 2003
Atopic dermatitis as a side effect of anti-tumor necrosis factor-alpha therapyHarald Mangge, Sonja Gindl, Harald Kenzian, et al.
Current Medicinal Chemistry|July 17, 2015
Lipoprotein-Related and Apolipoprotein-Mediated Delivery Systems for Drug Targeting and ImagingGunter Almer, Harald Mangge, Andreas Zimmer, et al.
European Heart Journal|June 23, 2023
SGLT2 inhibition could potentially impact inflammation in acute myocardial infarctionHarald Sourij, Faisal Aziz, Harald Mangge, et al.
Pageof 17